Scientists synthesized inaoside A from mushrooms, unlocking its bioactive potential for functional foods and medicines.

HMOs can also enhance the effectiveness of antibiotics against MDR bacteria by lowering the minimum inhibitory concentration (MIC) of various antibiotics (gentamicin, erythromycin, clindamycin and ...